Emma Akuffo, BSc, PhD, MBA
Director of Study Management

Emma oversees the Study Management, Advanced Research Science and Quality Assurance teams at Richmond Pharmacology.

During her 10 years at Richmond Pharmacology, Emma has worked on over 100 Early Phase Studies ensuring optimal delivery of clinical trial outcomes for our sponsors. This has been achieved through efficient, streamlined processes, the production of high quality documentation and stringent regulatory compliance.

Prior to working at Richmond Pharmacology, Emma worked on various drug development projects within the biotechnology and pharmaceutical industry as well as academia.

Emma is a full member of the British Pharmacological Society and holds a BSc in Biology & Chemistry, PhD in Biochemistry and an MBA.

Back to experts

Latest news

Richmond enrols first patients in Verve Therapeutic’s Heart-2 trial - pioneering a new approach to cardiovascular disease

June 27, 2024
Richmond enrols and doses the first patient in a clinical trial aimed at transforming the care of cardiovascular disease with single treatment gene-editing medicines.
Read more

A first of a kind trial in the fight against malaria

June 12, 2024
Richmond successfully recruits and enrols adults of sub-Saharan ancestry who all complete a first of its kind trial in the treatment of malaria.
Read more

Events

AHA Hypertension Scientific Sessions 2024

5 - 8 September 2024
Dr. Jörg Taubel, CEO of Richmond Pharmacology, will be attending the Hypertension 2024 Scientific Sessions
View event